PATENT CLAIM ANALYSIS

Application Number: 15861399
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "233200"]

Abstract:
The present invention relates to novel fused Imidazobenzothiazole derivatives, their pharmaceutically acceptable salts, and their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates, solvates and N-oxide. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.

Claim (Index 6):
The method according to  claim 1 , wherein the mammal is a human and the compound is administered in a dose of from 5 \u03bcg to 5 g per day.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.7619
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15128886', '15505902', '13639959', '15689075', '14424361']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7886913536019343
- 35 USC 102 Novelty (BERT): 0.5814394222244037
- Combined Prediction Score: 0.7679661604641812
- Mean Citation Score: 399.13778
- Max Citation Score: 583.3345
- Similarity Product: 344.94381096187243

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test